Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/15004
Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020
Euro Surveill. 2021 Jun;26(24):2100426.
We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy.
COVID-19 | Tuberculosis | COVID-19 Testing | Humans | Laboratories | Pandemics | SARS-CoV-2 | World Health Organization
Files in this item
- ImpactCOVID-19PandemicTubercul ...